Pan-intestinal capsule endoscopy as first-line procedure in patients with suspected mid or lower gastrointestinal bleeding.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
16 Feb 2024
Historique:
medline: 17 2 2024
pubmed: 17 2 2024
entrez: 16 2 2024
Statut: aheadofprint

Résumé

Pan-intestinal capsule endoscopy (PCE) evaluates the small-bowel and colon, non-invasively. To evaluate diagnostic accuracy and safety of PCE vs. colonoscopy as first-line examination in suspected mid-lower gastrointestinal bleeding (MLGIB). Prospective, single-centre, single-blinded cohort study. Consecutive patients with suspected MLGIB submitted to PCE followed by same-day colonoscopy. Diagnostic accuracy for potentially haemorrhagic lesions (PHL) (combined diagnosis by PCE + colonoscopy) and incidence of adverse events were assessed. One-hundred patients included, mean age 66,5 [70 (18-92)] years, 65% females. PHL were diagnosed in 46% of patients, corresponding to small-bowel and/or colon angioectasias in 70%. PCE correctly identified individuals without PHL in 50%, identifying 96% (44/46) of all individuals with PHL, vs. 50% (23/46) for colonoscopy, p<0,01. PHL were detected by PCE-only in 65% (30/46), both examinations in 28% (13/46), and colonoscopy-only in 6% (3/46). PHL were diagnosed at the ileo-colonic territory in 28% of patients; in those cases, PCE established the diagnosis in 25/28 (89%) of cases, vs. conventional colonoscopy in 23/28 (82%), p=0,125. Interventional procedures were performed at colonoscopy in 13/81 patients with iron-deficiency anaemia (IDA) (16%) vs. 6/19 patients with overt bleeding (31,6%), p<0,01. No significant adverse events occurred with PCE vs. 2% with colonoscopy. While assessing patients with MLGIB, PCE dismisses further invasive procedures in more than half of patients. Moreover, PCE is safe and more effective than colonoscopy in identifying PHL both in the small-bowel and colon. Our results support the potential use of PCE as first-line examination in patients with suspected MLGIB.

Identifiants

pubmed: 38365215
doi: 10.1055/a-2270-4601
doi:

Types de publication

Clinical Trial

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

Bruno Rosa has received consultancy fees from Medtronic, unrelated to the current work. All other authors declare no conflicts of interest.

Auteurs

Bruno Rosa (B)

Department of Gastroenterology, Hospital da Senhora da Oliveira, Guimarães, Portugal.
School of Medicine, University of Minho Life and Health Sciences Research Institute, Braga, Portugal.
PT Government Associate Laboratory, ICVS 3B's Associate Laboratory, Guimaraes, Portugal.

Tiago Cúrdia Gonçalves (T)

Gastrenterology, Hospital da Senhora da Oliveira, Guimaraes, Portugal.
School of Medicine, University of Minho, University of Minho Life and Health Sciences Research Institute, Braga, Portugal.
PT Government Associate Laboratory, ICVS 3B's Associate Laboratory, Guimaraes, Portugal.

Maria João Moreira (MJ)

Guimarães, Hospital da Senhora da Oliveira, Guimaraes, Portugal.
School of Medicine, University of Minho, University of Minho Life and Health Sciences Research Institute, Braga, Portugal.
PT Government Associate Laboratory, ICVS 3B's Associate Laboratory, Guimaraes, Portugal.

Francisca Dias Castro (FD)

Gastroenterology, Hospital da Senhora da Oliveira, Guimaraes, Portugal.
School of Medicine, University of Minho, University of Minho Life and Health Sciences Research Institute, Braga, Portugal.
PT Government Associate Laboratory, Braga/Guimarães, ICVS 3B's Associate Laboratory, Guimaraes, Portugal.

Bernardo Sousa-Pinto (B)

MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, University of Porto Faculty of Medicine, Porto, Portugal.
Center for Health Technology and Services Research, University of Porto, Porto, Portugal, CINTESIS, Porto, Portugal.

Mário Dinis-Ribeiro (M)

Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Portugal, MEDCIDS, Porto, Portugal.
Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), RISE@CI-IPO (Health Research Network), Porto, Portugal.

José Cotter (J)

Gastroenterology, Hospital da Senhora da Oliveira, Guimaraes, Portugal.
Life and Health Sciences Research Institute, Universidade do Minho, Braga/Guimarães, Portugal.
PT Government Associate Laboratory, ICVS 3B's Associate Laboratory, Guimaraes, Portugal.

Classifications MeSH